Literature DB >> 17619702

Antenatal hydronephrosis: differential diagnosis, evaluation, and treatment options.

C D Anthony Herndon1.   

Abstract

The diagnosis, evaluation and management of antenatal hydronephrosis has undergone a two stage paradigm shift since the advent of prenatal ultrasonography in the early 1980s. Initially the identification of a large number of asymptomatic infants appeared to afford the surgeon the opportunity for preemptive intervention. However, it has now become apparent that antenatal hydronephrosis (AH) is far more difficult to interpret than originally perceived. The initial enthusiasm for surgery has now been replaced by a much more conservative approach to ureteropelvic junction(UPJ) obstruction, multi-cystic dysplastic kidney(MCDK), vesicoureteral reflux and the non-refluxing megaureter. This review will highlight the postnatal evaluation of AH and include an overview of the Society for Fetal Urology grading system for hydronephrosis. The differential diagnosis and treatment options for UPJ obstruction, vesicoureteral reflux, MCDK, duplication anomalies, megaureter, and posterior urethral valves will be discussed.

Entities:  

Mesh:

Year:  2006        PMID: 17619702      PMCID: PMC5917328          DOI: 10.1100/tsw.2006.366

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  4 in total

Review 1.  Antenatal hydronephrosis.

Authors:  David M Kitchens; C D Anthony Herndon
Journal:  Curr Urol Rep       Date:  2009-03       Impact factor: 3.092

2.  [Congenital dilatation of the upper urinary tract : Current diagnostic and treatment concepts].

Authors:  R Beetz
Journal:  Urologe A       Date:  2018-08       Impact factor: 0.639

Review 3.  Mild to moderate postnatal hydronephrosis--grading systems and management.

Authors:  Matthew D Timberlake; C D Anthony Herndon
Journal:  Nat Rev Urol       Date:  2013-08-20       Impact factor: 14.432

4.  A New Grading System for the Management of Antenatal Hydronephrosis.

Authors:  Joana Dos Santos; Rulan S Parekh; Tino D Piscione; Tarek Hassouna; Victor Figueroa; Paula Gonima; Isis Vargas; Walid Farhat; Norman D Rosenblum
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.